BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 16297997)

  • 41. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique.
    Straczkowski M; Stepień A; Kowalska I; Kinalska I
    Med Sci Monit; 2004 Aug; 10(8):CR480-4. PubMed ID: 15277999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Characteristics of abnormal glucose tolerance in patients with polycystic ovary syndrome].
    Hu W; Hu WH; Qiao J; Wang LN; Zhao CY
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(29):2053-5. PubMed ID: 20017329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose dysregulation in obese children: predictive, risk, and potential protective factors.
    Xekouki P; Nikolakopoulou NM; Papageorgiou A; Livadas S; Voutetakis A; Magiakou MA; Chrousos GP; Spiliotis BE; Dacou-Voutetakis C
    Obesity (Silver Spring); 2007 Apr; 15(4):860-9. PubMed ID: 17426321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.
    Bardini G; Dicembrini I; Pala L; Cresci B; Rotella CM
    Diabet Med; 2011 Oct; 28(10):1229-33. PubMed ID: 21923697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.
    Meshkani R; Taghikhani M; Larijani B; Khatami S; Khoshbin E; Adeli K
    Clin Chim Acta; 2006 Sep; 371(1-2):169-75. PubMed ID: 16714005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction.
    Fujita M; Asanuma H; Kim J; Liao Y; Hirata A; Tsukamoto O; Minamino T; Hori M; Goto M; Node K; Kitakaze M
    Int J Cardiol; 2007 May; 118(1):76-80. PubMed ID: 16934350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of family history of type 2 diabetes on pancreatic beta-cell function.
    Wang ZH; Zhang SH; Gong LL; Ren W; Li R; Zheng RZ; Zhang YF; Wang MR; Li QF
    Diabetes Res Clin Pract; 2009 Oct; 86(1):61-6. PubMed ID: 19674808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test.
    Martinez-Hervas S; Argente C; Garcia-Jodar J; Priego A; Real JT; Carratala A; Carmena R; Ascaso JF
    Metabolism; 2011 May; 60(5):740-6. PubMed ID: 20850158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
    Gokulakrishnan K; Deepa R; Mohan V; Gross MD
    Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.
    Kang HW; Kim DJ; Lee MS; Kim KW; Lee MK
    Diabetes Res Clin Pract; 2005 Aug; 69(2):180-7. PubMed ID: 16005368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age?
    Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Heine R; Wareham NJ;
    Diabet Med; 2005 Nov; 22(11):1476-81. PubMed ID: 16241909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.
    Cho YM; Youn BS; Lee H; Lee N; Min SS; Kwak SH; Lee HK; Park KS
    Diabetes Care; 2006 Nov; 29(11):2457-61. PubMed ID: 17065684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes.
    Sarafidis PA; Lasaridis AN; Nilsson PM; Pikilidou MI; Stafilas PC; Kanaki A; Kazakos K; Yovos J; Bakris GL
    J Hum Hypertens; 2007 Sep; 21(9):709-16. PubMed ID: 17443211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Association of SNP276 in adiponectin gene with type 2 diabetes mellitus and insulin sensitivity].
    Ru Y; Ma M; Ma T; Wang CJ; Wang YM; Zhang Q; Chen MW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):698-701. PubMed ID: 16331577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.
    Gupta AK; Jain SK
    J Assoc Physicians India; 2004 Jul; 52():549-53. PubMed ID: 15645980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.